JP2017515888A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017515888A5 JP2017515888A5 JP2017502766A JP2017502766A JP2017515888A5 JP 2017515888 A5 JP2017515888 A5 JP 2017515888A5 JP 2017502766 A JP2017502766 A JP 2017502766A JP 2017502766 A JP2017502766 A JP 2017502766A JP 2017515888 A5 JP2017515888 A5 JP 2017515888A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- shock
- polyethylene glycol
- electrolytes
- aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461970247P | 2014-03-25 | 2014-03-25 | |
| US61/970,247 | 2014-03-25 | ||
| US201462019007P | 2014-06-30 | 2014-06-30 | |
| US62/019,007 | 2014-06-30 | ||
| PCT/US2015/022198 WO2015148474A1 (en) | 2014-03-25 | 2015-03-24 | Compositions for the treatment of autodigestion |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017515888A JP2017515888A (ja) | 2017-06-15 |
| JP2017515888A5 true JP2017515888A5 (cg-RX-API-DMAC7.html) | 2018-05-10 |
| JP6648106B2 JP6648106B2 (ja) | 2020-02-14 |
Family
ID=54188811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502766A Expired - Fee Related JP6648106B2 (ja) | 2014-03-25 | 2015-03-24 | 自己消化の治療用組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US9314442B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3122349B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6648106B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20220068266A (cg-RX-API-DMAC7.html) |
| CN (3) | CN106572987B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015236283B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2942358C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3122349T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2906262T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX376176B (cg-RX-API-DMAC7.html) |
| PL (1) | PL3122349T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3122349T (cg-RX-API-DMAC7.html) |
| TW (2) | TWI669114B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015148474A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012040595A2 (en) | 2010-09-23 | 2012-03-29 | Inflammagen | Administration of serine protease inhibitors to the stomach |
| ES2906262T3 (es) | 2014-03-25 | 2022-04-13 | Leading Biosciences Inc | Composiciones para el tratamiento de la autodigestión |
| CN113908281B (zh) * | 2016-01-11 | 2023-09-15 | 恒翼生物医药(上海)股份有限公司 | 用于治疗和预防粘连及肠梗阻的组合物和方法 |
| WO2019084186A1 (en) * | 2017-10-24 | 2019-05-02 | Leading BioSciences, Inc. | COMPOSITIONS AND METHODS FOR REGULATING GLUCOSE |
| US11666532B2 (en) | 2018-01-19 | 2023-06-06 | Hyloris Developments Sa | Tranexamic acid oral solution |
| CN110730413A (zh) * | 2018-06-29 | 2020-01-24 | 阿里巴巴集团控股有限公司 | 一种终端定位方法和装置 |
| US10980757B2 (en) | 2018-09-06 | 2021-04-20 | RTU Pharma SA | Ready-to-use tranexamic acid intravenous solution |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56158707A (en) * | 1980-04-08 | 1981-12-07 | Lion Corp | Composition for oral use |
| JP3496158B2 (ja) | 1993-01-26 | 2004-02-09 | 東洋カプセル株式会社 | トラネキサム酸配合ゼラチンカプセル製剤 |
| US5578568A (en) | 1994-04-22 | 1996-11-26 | Xoma Corporation | Method of treating conditions associated with intestinal ischemia/reperfusion |
| DE19617369A1 (de) | 1996-04-30 | 1997-11-06 | Immuno Ag | Lagerstabile Fibrinogen-Präparate |
| JP3940209B2 (ja) | 1996-11-14 | 2007-07-04 | 株式会社資生堂 | 可溶化化粧料 |
| US6121232A (en) | 1997-01-31 | 2000-09-19 | Omrix Biopharmaceuticals Sa | Stabilized mixture comprising fibrinogen |
| WO1999008514A1 (en) | 1997-08-20 | 1999-02-25 | Lxr Biotechnology, Inc. | Compositions containing polyethylene glycol and uses thereof |
| TWI243687B (en) | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
| DE10025001A1 (de) | 2000-05-22 | 2001-11-29 | Aventis Behring Gmbh | Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften |
| US7276235B2 (en) | 1998-11-18 | 2007-10-02 | Zlb Behring Gmbh | Tissue glue with improved antiadhesive properties |
| WO2001037854A1 (en) | 1999-11-24 | 2001-05-31 | The Regents Of The University Of California | Method for treatment and prevention of physiological shock |
| US6708822B1 (en) | 1999-11-30 | 2004-03-23 | Cutispharma, Inc. | Compositions and kits for compounding pharmaceuticals |
| US20030144212A1 (en) | 2000-07-06 | 2003-07-31 | Hoffman Keith B | Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host |
| JP4044748B2 (ja) | 2001-10-17 | 2008-02-06 | サンスター株式会社 | 口腔用液体組成物 |
| US20040018984A1 (en) | 2002-07-17 | 2004-01-29 | Mizuo Miyazaki | Methods for preventing adhesion formation using protease inhibitors |
| GB0224909D0 (en) | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
| PT1567117E (pt) | 2002-11-26 | 2012-05-09 | Univ Chicago | Prevenção e tratamento de distúrbios epiteliais mediados por micróbios |
| US20050025825A1 (en) | 2003-07-31 | 2005-02-03 | Xanodyne Pharmacal, Inc. | Tranexamic acid formulations with reduced adverse effects |
| JP2005068076A (ja) | 2003-08-25 | 2005-03-17 | Tendou Seiyaku Kk | トラネキサム酸類を含む外用液剤および清拭剤 |
| US20090215898A1 (en) | 2004-03-04 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
| MXPA06012070A (es) | 2004-04-20 | 2007-04-24 | Univ Chicago | Sistema de surtido terapeutico que comprende un compuesto de tipo peg de peso molecular alto. |
| US20080194611A1 (en) | 2005-06-03 | 2008-08-14 | Alverdy John C | Modulation of Cell Barrier Dysfunction |
| CA2609985A1 (en) | 2005-06-03 | 2007-05-10 | The University Of Chicago | Modulation of cell barrier dysfunction |
| CA2610951A1 (en) | 2005-06-03 | 2006-12-14 | The University Of Chicago | Modulation of microbial pathogen-host cell interactions |
| WO2007101264A2 (en) | 2006-02-28 | 2007-09-07 | The University Of Chicago | Method for treating endothelial and epithelial cell disorders by administering high molecular weight peg-like compounds |
| JP5465824B2 (ja) | 2006-03-24 | 2014-04-09 | 第一三共ヘルスケア株式会社 | 医薬用製剤およびその製造方法 |
| US20100179091A1 (en) | 2007-02-20 | 2010-07-15 | The Regents Of The University Of California | Treatment of Conditions Related to Shock |
| JP5093841B2 (ja) | 2007-07-12 | 2012-12-12 | 株式会社 資生堂 | 不織布含浸化粧料 |
| WO2009045543A1 (en) | 2007-10-04 | 2009-04-09 | The Regents Of The University Of California | Treatment of conditions related to shock |
| WO2010087874A1 (en) | 2009-01-28 | 2010-08-05 | Anazyme, Llc | Compositions and methods for diagnosis of shock |
| WO2009132149A2 (en) | 2008-04-22 | 2009-10-29 | The Regents Of The University Of California | Treatment of conditions related to cecal ligation shock |
| PT2294012E (pt) | 2008-05-07 | 2014-10-15 | Salix Pharmaceuticals Ltd | Administração de um agente de limpeza intestinal e de um antibiótico para o tratamento de doença intestinal |
| US7635707B1 (en) * | 2008-11-10 | 2009-12-22 | Intermune, Inc. | Pirfenidone treatment for patients with atypical liver function |
| ZA201107285B (en) | 2009-03-06 | 2012-12-27 | Delivtx Inc | Microencapsulated bioactive agents for oral delivery and methods of the thereof |
| WO2010111294A1 (en) | 2009-03-23 | 2010-09-30 | The University Of Chicago | Methods for preventing and treating radiation-induced epithelial disorders |
| US8852155B2 (en) * | 2009-08-12 | 2014-10-07 | Medimetrics Personalized Drug Delivery | Medicine reservoir for drug delivery device |
| US20110060040A1 (en) | 2009-09-04 | 2011-03-10 | Xenoport, Inc. | Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid |
| WO2011103591A1 (en) | 2010-02-22 | 2011-08-25 | Edge Therapeutics Inc. | Methods and compositions to treat hemorrhagic conditions of the brain |
| WO2012040595A2 (en) | 2010-09-23 | 2012-03-29 | Inflammagen | Administration of serine protease inhibitors to the stomach |
| EP2621521A4 (en) | 2010-10-02 | 2014-04-23 | Univ California | MINIMIZING DARMDYS FUNCTIONS |
| JP6148454B2 (ja) * | 2011-11-11 | 2017-06-14 | ロート製薬株式会社 | トラネキサム酸を含む外用及び内服用組成物 |
| ES2375784B1 (es) | 2011-12-22 | 2013-01-24 | Laboratorios Kin S.A. | Gel de ácido tranexámico |
| CN103565743B (zh) | 2012-07-23 | 2016-06-22 | 上海市徐汇区中心医院 | 氨甲环酸皮肤外用纳米制剂及其制备方法和用途 |
| US9937199B2 (en) | 2012-08-17 | 2018-04-10 | The University Of Chicago | Materials and methods for preventing and treating anastomotic leaks |
| CN103054861A (zh) * | 2012-12-29 | 2013-04-24 | 北京阜康仁生物制药科技有限公司 | 一种含氨甲环酸的复方固体制剂 |
| US20140271923A1 (en) * | 2013-03-14 | 2014-09-18 | Christopher Brian Reid | Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions |
| ES2906262T3 (es) | 2014-03-25 | 2022-04-13 | Leading Biosciences Inc | Composiciones para el tratamiento de la autodigestión |
| US20150297619A1 (en) | 2014-04-17 | 2015-10-22 | The Regents Of The University Of California | Methods and compositions for preserving the mucosal barrier |
-
2015
- 2015-03-24 ES ES15767838T patent/ES2906262T3/es active Active
- 2015-03-24 WO PCT/US2015/022198 patent/WO2015148474A1/en not_active Ceased
- 2015-03-24 CA CA2942358A patent/CA2942358C/en active Active
- 2015-03-24 CN CN201580020501.9A patent/CN106572987B/zh active Active
- 2015-03-24 AU AU2015236283A patent/AU2015236283B2/en not_active Ceased
- 2015-03-24 CN CN202110088870.9A patent/CN112641771B/zh active Active
- 2015-03-24 CN CN202110088873.2A patent/CN112807325A/zh active Pending
- 2015-03-24 PL PL15767838T patent/PL3122349T3/pl unknown
- 2015-03-24 JP JP2017502766A patent/JP6648106B2/ja not_active Expired - Fee Related
- 2015-03-24 MX MX2016012248A patent/MX376176B/es active IP Right Grant
- 2015-03-24 KR KR1020227015575A patent/KR20220068266A/ko not_active Ceased
- 2015-03-24 KR KR1020167027915A patent/KR102397379B1/ko active Active
- 2015-03-24 US US14/666,926 patent/US9314442B2/en active Active
- 2015-03-24 EP EP15767838.4A patent/EP3122349B1/en active Active
- 2015-03-24 DK DK15767838.4T patent/DK3122349T3/da active
- 2015-03-24 PT PT157678384T patent/PT3122349T/pt unknown
- 2015-03-25 TW TW105125832A patent/TWI669114B/zh not_active IP Right Cessation
- 2015-03-25 TW TW104109588A patent/TWI554269B/zh not_active IP Right Cessation
-
2016
- 2016-03-14 US US15/069,860 patent/US9775821B2/en not_active Expired - Fee Related
-
2017
- 2017-09-18 US US15/707,943 patent/US11123317B2/en not_active Expired - Fee Related
-
2021
- 2021-08-28 US US17/460,184 patent/US20220054439A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017515888A5 (cg-RX-API-DMAC7.html) | ||
| JP2019515908A5 (cg-RX-API-DMAC7.html) | ||
| JP2018530592A5 (cg-RX-API-DMAC7.html) | ||
| HRP20180007T1 (hr) | Formulacija koja sadrži gemcitabin-predlijek | |
| RU2018114447A (ru) | Введение дейтерированных усилителей cftr | |
| JP2016510326A5 (cg-RX-API-DMAC7.html) | ||
| JP2012255026A5 (cg-RX-API-DMAC7.html) | ||
| HRP20240168T1 (hr) | Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije | |
| RU2010114033A (ru) | Применение ингибитора nf-каппа в sn50 и необязательно ангиотензина iii в качестве терапевтических средств при лечении, например, инфекции hbv | |
| JP2008001724A5 (cg-RX-API-DMAC7.html) | ||
| JP2017513836A5 (cg-RX-API-DMAC7.html) | ||
| JP2013518056A5 (cg-RX-API-DMAC7.html) | ||
| JP2015529234A5 (cg-RX-API-DMAC7.html) | ||
| RU2013138672A (ru) | Способ, композиция и набор для чистки кишечника | |
| JP2016512210A5 (cg-RX-API-DMAC7.html) | ||
| JP2016511753A5 (cg-RX-API-DMAC7.html) | ||
| FI3817751T3 (fi) | Vedettömän natriumtiosulfaatin formulaatioita | |
| JP2019535760A5 (ja) | ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法 | |
| JP2016529306A5 (cg-RX-API-DMAC7.html) | ||
| JP6648106B2 (ja) | 自己消化の治療用組成物 | |
| JP2017200948A5 (cg-RX-API-DMAC7.html) | ||
| RU2013112807A (ru) | Композиция для доставки активных агентов в желудок | |
| JP2017105861A5 (cg-RX-API-DMAC7.html) | ||
| HRP20210010T1 (hr) | Injekcijske farmaceutske formulacije lefamulina | |
| RU2008111148A (ru) | Применение комплексных соединений железа (iii) для производства лекарственного средства для перорального лечения железодефицитных состояний у больных, страдающих хроническими воспалительными заболеваниями кишечника |